BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu S, Piao H, Rejinold NS, Jin G, Choi G, Choy JH. Niclosamide-Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment. Polymers (Basel) 2021;13:1044. [PMID: 33810527 DOI: 10.3390/polym13071044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mahmud N, Anik MI, Hossain MK, Khan MI, Uddin S, Ashrafuzzaman M, Rahaman MM. Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments. ACS Appl Bio Mater 2022. [PMID: 35583460 DOI: 10.1021/acsabm.2c00123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 MotieGhader H, Safavi E, Rezapour A, Amoodizaj FF, Iranifam RA. Drug repurposing for coronavirus (SARS-CoV-2) based on gene co-expression network analysis. Sci Rep 2021;11:21872. [PMID: 34750486 DOI: 10.1038/s41598-021-01410-3] [Reference Citation Analysis]
3 Choi G, Piao H, Rejinold NS, Yu S, Kim KY, Jin GW, Choy JH. Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections. Pharmaceuticals (Basel) 2021;14:486. [PMID: 34069716 DOI: 10.3390/ph14050486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Sa'adon S, Ansari MNM, Razak SIA, Anand JS, Nayan NHM, Ismail AE, Khan MUA, Haider A. Preparation and Physicochemical Characterization of a Diclofenac Sodium-Dual Layer Polyvinyl Alcohol Patch. Polymers (Basel) 2021;13:2459. [PMID: 34372062 DOI: 10.3390/polym13152459] [Reference Citation Analysis]
5 Rejinold N S, Choi G, Piao H, Choy JH. Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19. Materials (Basel) 2021;14:3792. [PMID: 34300711 DOI: 10.3390/ma14143792] [Reference Citation Analysis]
6 Piao H, Rejinold NS, Choi G, Pei YR, Jin GW, Choy JH. Niclosamide encapsulated in mesoporous silica and geopolymer: A potential oral formulation for COVID-19. Microporous Mesoporous Mater 2021;326:111394. [PMID: 34483712 DOI: 10.1016/j.micromeso.2021.111394] [Reference Citation Analysis]
7 Rejinold NS, Piao H, Choi G, Jin GW, Choy JH. NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100. Clays Clay Miner 2021;:1-14. [PMID: 34785820 DOI: 10.1007/s42860-021-00153-6] [Reference Citation Analysis]
8 Prasher P, Sharma M. Mucoadhesive nanoformulations and their potential for combating COVID-19. Nanomedicine (Lond) 2021;16:2497-501. [PMID: 34730403 DOI: 10.2217/nnm-2021-0287] [Reference Citation Analysis]